Centene Corporation Faces Class Action Lawsuit Over Alleged False and Misleading Statements

Strategic Insights -

Centene Corporation, a multi-national healthcare company, has been accused of providing investors with false and misleading information about its expected revenue guidance and adjusted diluted earnings per share for the 2025 fiscal year. Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of purchasers of Centene securities between December 12, 2024, and June 30, 2025. The lawsuit alleges that defendants concealed material adverse facts concerning the true state of Centene's enrollment and morbidity rates.

Key Takeaways:

  • The class action lawsuit was filed by Rosen Law Firm on behalf of Centene common stock purchasers between December 12, 2024, and June 30, 2025.
  • The lawsuit alleges that Centene's defendants provided investors with material information concerning the company's expected revenue guidance and adjusted diluted earnings per share for the 2025 fiscal year.
  • Defendants are accused of concealing material adverse facts concerning the true state of Centene's enrollment and morbidity rates.
  • The lawsuit claims that investors may be entitled to compensation without paying out-of-pocket fees or costs through a contingency fee arrangement.
  • A lead plaintiff is required to represent the interests of other class members in directing the litigation, and a motion must be filed with the court by September 8, 2025, to serve as lead plaintiff.

Statistics:

  • The alleged period of false and misleading statements spans from December 12, 2024, to June 30, 2025.
  • The law firm, Rosen Law Firm, has secured over $438 million for investors in 2019 and has been ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Sources:

  • Newsfile Corp. press release (July 20, 2025)
  • Rosen Law Firm (https://www.rosenlegal.com/)
  • ISS Securities Class Action Services
  • Law360 (2020)